Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2026The Accounting Review

Cost Accounting for the Pharmaceutical Industry (Book).

View Full Paper
Ask AI
Bookmark
Share

Authors

JNJohn J. W. NeunerBaruch CollegeACArthur M. Cannon

Discussion

Loading...

Member takes

Implication

This review evaluates cost accounting principles, outcomes for businesses, and implications for the pharmaceutical sector.

Key Points

  • The aim is to evaluate the principles and practices of cost accounting highlighted in the book.
  • Review of key concepts presented in the book
  • Analysis of applicability to the pharmaceutical industry
  • Discussion of financial implications
  • Identifies strengths and weaknesses of current cost accounting methods
  • Explains the impact of financial analysis on pricing strategies
  • Highlights the importance of regulatory compliance in financial practices

Cite This Study

Neuner et al. (1952) studied this question.

synapsesocial.com/papers/69ba42bc4e9516ffd37a34a2https://doi.org/10.2308/tar-7126099
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Developments in Cost Accounting (Book).1948
  2. 2Managerial Cost Accounting for Hospitals (Book).1981
  3. 3Accounting and Cost Finding for the Chemical Industries (Book).1931
  4. 4Cost Finding for Hospitals (Book).1958
  5. 5Cost Accounting (Book).1987